The complexity of chemotherapy options today calls for an assist from augmented intelligence.
Early identification and treatment are key to optimizing function and quality of life.
Vanderbilt adds a new fellowship focusing on innovative procedures and rare diseases.
Join our experts as they share their latest discoveries in cancer biology, clinical studies and translational initiatives.
Judicious selection and timing can raise success rates of CRS-HIPEC.
1 / 5
Massive studies shed light on increased risk.
Rise of genetic tumor sequencing calls for new communities of experts.
A distinct genomic landscape among young adults points to clinical actionability.